NCT06040671

Brief Summary

An objective assessment of that part of the spectrum of ophthalmic eyelid surgeries that focuses on correcting the position of entropy (e.g. ectropion, ptosis surgery) is very difficult - although it is possible to use different measuring parameters (distance of pupillary reflexes from the edges of the eyelid), comparing different distances on the face, exophthalmometry or the lid laxity test - the so-called snap-back test, but all these methods are based either on the subjective assessment of the examiner or on the correctness of the attached ruler, and their objectivity is therefore very low.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2021

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

October 31, 2022

Completed
11 months until next milestone

First Posted

Study publicly available on registry

September 15, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

September 15, 2023

Status Verified

September 1, 2023

Enrollment Period

2.7 years

First QC Date

October 31, 2022

Last Update Submit

September 8, 2023

Conditions

Keywords

Vectra M3 deviceEyelid Ptosesstereo photographic systemeyelid surgery

Outcome Measures

Primary Outcomes (2)

  • Distance between anatomical points on the face

    In all patients, distance between 52 anatomical-topographical points on the face will be measured in millimetres (mm) - change of the position of the eyelids before and after surgery (distance in mm), the relation of the eyelids to the periorbital landscape (distance in mm)

    6 months

  • Periorbital volume measurement

    In all patients, the periorbital volume (volume in mm3) will be assessed metrically.

    6 months

Secondary Outcomes (1)

  • The possibility to use the Vectra M 3D Imaging System in other ophthalmological indications

    3 years

Study Arms (2)

Lateral canthal hinge surgery patients

EXPERIMENTAL

Patients undergoing lateral canthal hinge surgery will be enrolled in this group.

Other: Vectra M3 imaging

Ptosis surgery patients

EXPERIMENTAL

Patients undergoing ptosis surgery will be enrolled in this group.

Other: Vectra M3 imaging

Interventions

Study subjects from both arms will undergo Vectra M3 imaging to evaluate the result of the surgery.

Lateral canthal hinge surgery patientsPtosis surgery patients

Eligibility Criteria

Age4 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Eyelid ptosis
  • Eyelid entropion
  • Eyelid ectropion

You may not qualify if:

  • Refusal to participate in the study
  • Not signing the Informed Consent Form
  • Inability/reluctance to cooperate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, 70852, Czechia

RECRUITING

MeSH Terms

Conditions

BlepharoptosisEctropionEntropion

Condition Hierarchy (Ancestors)

Eyelid DiseasesEye Diseases

Study Officials

  • Adam Kopecký, MD,PhD,FEBO

    University Hospital Ostrava

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jiří Hynčica

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
No masking is used in the study.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: The study subjects will be divided into two groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 31, 2022

First Posted

September 15, 2023

Study Start

May 3, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

September 15, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data available to other researchers; however, the data may be provided upon request.

Locations